- Home
- FSP vs XBIT Comparison
FSP vs XBIT Comparison
Compare FSP & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSP | XBIT |
|---|---|---|
| Founded | 1981 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Pharmaceuticals and Biotechnology |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 71.3M |
| IPO Year | 2001 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FSP | XBIT |
|---|---|---|
| Price | $0.60 | $2.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 604.8K | 25.1K |
| Earning Date | 06-10-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.67% | N/A |
| EPS Growth | ★ 15.69 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $107,162,000.00 | N/A |
| Revenue This Year | $17.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.59 | $2.09 |
| 52 Week High | $1.93 | $3.62 |
Technical Indicators
Market Signals| Indicator | FSP | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 31.78 | 38.49 |
| Support Level | N/A | $2.15 |
| Resistance Level | $0.89 | $2.69 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 0.00 | 3.45 |
Price Performance
Historical ComparisonAbout FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.